Treatment of Atopic Dermatitis by a Full-Body Blue Light Device

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Multicentric, placebo-controlled, double-blinded, three-armed, prospective, randomized controlled trial.150 patients diagnosed with atopic dermatitis will be randomized to arm 1 (irradiation for 30min at 415nm wavelength), arm 2 (irradiation for 30min at 450nm wavelength), and arm 3 (irradiation for 30min at low-dose (placebo)). Irradiation will be scheduled 3 times a week for 8 weeks. Patients will be followed up for four weeks after the last irradiation.
Epistemonikos ID: 0c1eeb99faee9be4b5ee7b28ee6e485d7d936f95
First added on: May 22, 2024